AAAAAA
Results: 1-25/46
Authors:
BORDEN EC
Citation: Ec. Borden, AUGMENTING CLINICAL EFFICACY OF INTERFERONS, European cytokine network, 9(3), 1998, pp. 381-381
Authors:
WALTER MR
BORDENS R
NAGABHUSHAN TL
WILLIAMS BRG
HERBERMAN RB
DINARELLO CA
BORDEN EC
TROTTA PP
PESTKA S
PFEFFER LM
Citation: Mr. Walter et al., REVIEW OF RECENT DEVELOPMENTS IN THE MOLECULAR CHARACTERIZATION OF RECOMBINANT ALPHA-INTERFERONS ON THE 40TH ANNIVERSARY OF THE DISCOVERY OF INTERFERON, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 143-154
Authors:
BORDEN EC
Citation: Ec. Borden, COMPARATIVE PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 RECOMBINANT HUMAN INTERFERON-BETA 1A (IFN-BETA-1A) PRODUCTS ADMINISTERED INTRAMUSCULARLY IN HEALTHY MALE AND FEMALE VOLUNTEERS, Pharmaceutical research, 15(1), 1998, pp. 2-2
Authors:
ROSENTHAL MA
GREEN M
WIERNIK P
BORDEN EC
MARSH JC
HALLER DG
Citation: Ma. Rosenthal et al., EPIRUBICIN HAS MODEST SINGLE-AGENT ACTIVITY IN HEAD AND NECK-CANCER BUT LIMITED ACTIVITY IN METASTATIC MELANOMA AND COLORECTAL-CANCER - PHASE-II STUDIES BY THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP, American journal of clinical oncology, 21(5), 1998, pp. 509-512
Authors:
BORDEN EC
PARKINSON D
Citation: Ec. Borden et D. Parkinson, SIDE-EFFECTS OF INTERFERON-ALPHA - POSSIBLE CLINICAL CAUSES AND INTERVENTION STRATEGIES - INTRODUCTION, Seminars in oncology, 25(1), 1998, pp. 1-2
Authors:
BORDEN EC
PARKINSON D
Citation: Ec. Borden et D. Parkinson, A PERSPECTIVE ON THE CLINICAL EFFECTIVENESS AND TOLERANCE OF INTERFERON-ALPHA, Seminars in oncology, 25(1), 1998, pp. 3-8
Authors:
PFEFFER LM
DINARELLO CA
HERBERMAN RB
WILLIAMS BRG
BORDEN EC
BORDENS R
WALTER MR
NAGABHUSHAN TL
TROTTA PP
PESTKA S
Citation: Lm. Pfeffer et al., BIOLOGICAL PROPERTIES OF RECOMBINANT ALPHA-INTERFERONS - 40TH ANNIVERSARY OF THE DISCOVERY OF INTERFERONS, Cancer research, 58(12), 1998, pp. 2489-2499
Authors:
ABDULAHAD AK
GALAZKA AR
REVEL M
BIFFONI M
BORDEN EC
Citation: Ak. Abdulahad et al., INCIDENCE OF ANTIBODIES TO INTERFERON-BETA IN PATIENTS TREATED WITH RECOMBINANT HUMAN INTERFERON-BETA-1A FROM MAMMALIAN-CELLS, Cytokines cellular & molecular therapy, 3(1), 1997, pp. 27-32
Authors:
LINDNER DJ
BORDEN EC
Citation: Dj. Lindner et Ec. Borden, SYNERGISTIC ANTITUMOR EFFECTS OF A COMBINATION OF INTERFERON AND TAMOXIFEN ON ESTROGEN RECEPTOR-POSITIVE AND RECEPTOR-NEGATIVE HUMAN TUMOR-CELL LINES IN-VIVO AND IN-VITRO, Journal of interferon & cytokine research, 17(11), 1997, pp. 681-693
Authors:
LINDNER DJ
BORDEN EC
KALVAKOLANU DV
Citation: Dj. Lindner et al., SYNERGISTIC ANTITUMOR EFFECTS OF A COMBINATION OF INTERFERONS AND RETINOIC ACID ON HUMAN TUMOR-CELLS IN-VITRO AND IN-VIVO, Clinical cancer research, 3(6), 1997, pp. 931-937
Authors:
KIRKWOOD JM
BRYANT J
SCHILLER JH
OKEN MM
BORDEN EC
WHITESIDE TL
Citation: Jm. Kirkwood et al., IMMUNOMODULATORY FUNCTION OF INTERFERON-GAMMA IN PATIENTS WITH METASTATIC MELANOMA - RESULTS OF A PHASE II-B TRIAL IN SUBJECTS WITH METASTATIC MELANOMA, ECOG STUDY E-4987, Journal of immunotherapy with emphasis on tumor immunology, 20(2), 1997, pp. 146-157
Authors:
MACKOWIAK PA
BARTLETT JG
BORDEN EC
GOLDBLUM SE
HASDAY JD
MUNFORD RS
NASRAWAY SA
STOLLEY PD
WOODWARD TE
Citation: Pa. Mackowiak et al., CONCEPTS OF FEVER - RECENT ADVANCES AND LINGERING DOGMA, Clinical infectious diseases, 25(1), 1997, pp. 119-138
Authors:
BORDEN EC
LINDNER DL
SCHWARTZ E
Citation: Ec. Borden et al., INCREASING INTERFERONS (IFNS) EFFECTIVENESS THROUGH AUGMENTATION OF GENE-EXPRESSION, European journal of cancer, 33, 1997, pp. 9-9
Authors:
LINDNER DJ
KOLLA V
KALVAKOLANU DV
BORDEN EC
Citation: Dj. Lindner et al., TAMOXIFEN ENHANCES INTERFERON-REGULATED GENE-EXPRESSION IN BREAST-CANCER CELLS, Molecular and cellular biochemistry, 167(1-2), 1997, pp. 169-177
Authors:
LINDNER DJ
KALVAKOLANU DV
BORDEN EC
Citation: Dj. Lindner et al., INCREASING EFFECTIVENESS OF INTERFERON-ALPHA FOR MALIGNANCIES, Seminars in oncology, 24(3), 1997, pp. 999-9104
Authors:
LINDNER DJ
BORDEN EC
Citation: Dj. Lindner et Ec. Borden, EFFECTS OF TAMOXIFEN AND INTERFERON-BETA OR THE COMBINATION ON TUMOR-INDUCED ANGIOGENESIS, International journal of cancer, 71(3), 1997, pp. 456-461
Authors:
WITT PL
ZAHIR S
RITCH PS
MCAULIFFE TM
EWEL CH
BORDEN EC
Citation: Pl. Witt et al., PHASE I IB STUDY OF POLYADENYLIC-POLYURIDYLIC ACID IN PATIENTS WITH ADVANCED MALIGNANCIES - CLINICAL AND BIOLOGIC EFFECTS/, Journal of interferon & cytokine research, 16(8), 1996, pp. 631-635
Authors:
BYHARDT RW
VAICKUS L
WITT PL
CHANG AY
MCAULIFFE T
WILSON JF
LAWTON CA
BREITMEYER J
ALGER ME
BORDEN EC
Citation: Rw. Byhardt et al., RECOMBINANT HUMAN INTERFERON-BETA (RHUIFN-BETA) AND RADIATION-THERAPYFOR INOPERABLE NONSMALL CELL LUNG-CANCER, Journal of interferon & cytokine research, 16(11), 1996, pp. 891-902
Authors:
TAYLOR JL
DCUNHA J
TOM P
OBRIEN WJ
BORDEN EC
Citation: Jl. Taylor et al., PRODUCTION OF ISG-15, AN INTERFERON-INDUCIBLE PROTEIN, IN HUMAN CORNEAL CELLS, Journal of interferon & cytokine research, 16(11), 1996, pp. 937-940
Authors:
KEEVERTAYLOR CA
WITT PL
TRUITT RL
RAMANUJAM S
BORDEN EC
RITCH PS
Citation: Ca. Keevertaylor et al., HEMATOLOGIC AND IMMUNOLOGICAL EVALUATION OF RECOMBINANT HUMAN INTERLEUKIN-6 IN PATIENTS WITH ADVANCED MALIGNANT DISEASE - EVIDENCE FOR MONOCYTE ACTIVATION, Journal of immunotherapy with emphasis on tumor immunology, 19(3), 1996, pp. 231-243
Authors:
KALVAKOLANU DV
BORDEN EC
Citation: Dv. Kalvakolanu et Ec. Borden, AN OVERVIEW OF THE INTERFERON SYSTEM - SIGNAL-TRANSDUCTION AND MECHANISMS OF ACTION, Cancer investigation, 14(1), 1996, pp. 25-53
Authors:
BORDEN EC
WADLER S
Citation: Ec. Borden et S. Wadler, INTERFERONS AS BIOCHEMICAL MODULATORS, Journal of clinical oncology, 14(10), 1996, pp. 2627-2630
Authors:
KIRKWOOD JM
STRAWDERMAN MH
ERNSTOFF MS
SMITH TJ
BORDEN EC
BLUM RH
Citation: Jm. Kirkwood et al., INTERFERON ALFA-2B ADJUVANT THERAPY OF HIGH-RISK RESECTED CUTANEOUS MELANOMA - THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP TRIAL EST 1684, Journal of clinical oncology, 14(1), 1996, pp. 7-17
Authors:
JACOBS LD
COOKFAIR DL
RUDICK RA
HERNDON RM
RICHERT JR
SALAZAR AM
FISCHER JS
GOODKIN DE
GRANGER CV
SIMON JH
ALAM JJ
BARTOSZAK DM
BOURDETTE DN
BRAIMAN J
BROWNSCHEIDLE CM
COATS ME
COHAN SL
DOUGHERTY DS
KINKEL RP
MASS MK
MUNSCHAUER FE
PRIORE RL
PULLICINO PM
SCHEROKMAN BJ
WEINSTOCKGUTTMAN B
WHITMAN RH
BAIRD WC
FILLMORE M
BONA LM
COLONRUIZ ME
NADINE BS
DONOVAN A
BENNETT S
KIEFFER YM
UMHAUER MA
MILLER CE
KILIC AK
SARGENT EL
SCHACHTER M
SHUCARD DW
WEIDER V
CATALANO BA
CERVI JM
CZEKAY C
FARRELL JL
FILIPPINI JS
MATYAS RC
MICHIENZI KE
ITO M
OMALLEY JA
ZIELEZNY MA
BRUN JM
DAVIDSON AL
GREEN LA
OREILLY KM
SHELTON JA
WENDE KE
BARILLA DY
BOYLE SL
PERKINS KK
PERRYMAN JE
STIEBELING BG
KONECSNI JF
ROSS JS
CHOI KS
GUSTAFSON CJ
QUANDT BJ
SCHERZINGER AL
GRIFFITH DA
HARRIS JM
LEZAK MD
MIMICA I
SAUNDERS JA
COIT WE
FORCE CR
GILMORE FJ
HARRIS LB
JONES MM
KAUFFMAN JA
MARBERGER KE
MCBRIDE JW
MILLER LL
WRIGHT GK
BROOKS JA
BROWN HR
GRAVES ME
SCHMIDT JA
MOTHENA JW
GRAFMAN JH
KENWORTHY MK
MORTON MM
BROWN DM
BROWN DC
LEVY LM
BORDEN EC
RANSOHOFF RM
VILCEK JT
MCCARTHYKIRBY K
CAMPION M
Citation: Ld. Jacobs et al., INTRAMUSCULAR INTERFERON BETA-1-ALPHA FOR DISEASE PROGRESSION IN RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 39(3), 1996, pp. 285-294
Authors:
DCUNHA J
KNIGHT E
HAAS AL
TRUITT RL
BORDEN EC
Citation: J. Dcunha et al., IMMUNOREGULATORY PROPERTIES OF ISG15, AN INTERFERON-INDUCED CYTOKINE, Proceedings of the National Academy of Sciences of the United Statesof America, 93(1), 1996, pp. 211-215